Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

METHYS Dx

METHYS Dx develops methylation marker panels for ctDNA characterization in liquid biopsies, focusing on non-invasive cancer monitoring.
2021
11-50
Paris, Ile-de-France, France
  • Bioanalytical Devices
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information